Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

ANLATNM

Adlai Nortye Ltd.

ANL · $10.58

54Fair

Actinium Pharmaceuticals, Inc.

ATNM · $1.52

78Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

ANL

54/100

ATNM

78/100

Quality

Is it a profitable, well-run business?

ANL

2.0/10

ATNM

9.5/10

Growth

Is the company growing?

ANL

9.0/10

ATNM

5.9/10

Valuation

Is the price reasonable? (higher = cheaper)

ANL

0.0/10

ATNM

8.8/10

Risk

How risky are the shares? (higher = lower risk)

ANL

1.7/10

ATNM

5.0/10

Momentum

Is the share price trending up?

ANL

3.5/10

ATNM

8.4/10

Financial strength

Is the balance sheet healthy?

ANL

6.3/10

ATNM

5.8/10

The balanced view

Model-generated

Adlai Nortye Ltd.

This company has a mixed profile, with solid growth and supportive analyst views, although its current valuation deserves attention.

Leads on: growth, financial strength

Best feature: solid growth (Forward revenue growth: 244.0%)

Watch out: valuation may be demanding (P/E (TTM): -5.4x)

Actinium Pharmaceuticals, Inc.

This company scores well across most areas, with supportive analyst views and strong profitability.

Leads on: quality, valuation, risk, momentum

Best feature: analysts broadly positive (Analyst buy share: 100%)

Watch out: weakest area: risk profile (Price volatility (1Y, annualised): 72%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.